GOLDMAN SACHS GROUP INC - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 39 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.

Links
Filings
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2015$13,000
-7.1%
15,0000.0%0.00%–
Q2 2015$14,0000.0%15,0000.0%0.00%–
Q1 2015$14,0000.0%15,0000.0%0.00%–
Q4 2014$14,000
-6.7%
15,0000.0%0.00%–
Q3 2014$15,000
-11.8%
15,0000.0%0.00%–
Q2 2014$17,000–15,000–0.00%–
 Download
Other shareholders

There were no reported owners of PDL BIOPHARMA INC in Q3 2015.

NameSharesValueWeighting ↓
View complete list of PDL BIOPHARMA INC shareholders